Related Experiment Videos
Intranasal salbutamol instillation in asthma attack
N Weksler1, S Brill, A Tarnapolski
1Division of Anesthesiology, Soroka University Medical Center, Faculty of Medical Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
The American Journal of Emergency Medicine
|December 22, 1999
Summary
Nasal salbutamol offers a promising alternative for severe asthma attacks unresponsive to standard treatments. This route effectively delivered the beta-two sympathomimetic, providing relief without significant side effects.
Area of Science:
- Pharmacology
- Respiratory Medicine
- Drug Delivery Systems
Background:
- Beta-two sympathomimetics are primary treatments for asthma attacks, acting on beta-two adrenoreceptors to dilate bronchi and inhibit mast cell mediator release.
- Salbutamol, a common beta-two sympathomimetic, is typically administered via inhalation, oral, or parenteral routes.
- The nasal route presents potential advantages for drug administration due to large mucosal surface area and avoidance of first-pass metabolism.
Observation:
- This study explored the efficacy of nasal salbutamol in three patients experiencing severe asthma attacks.
- These patients were refractory to conventional asthma therapies.
- The administration was specifically via the nasal route.
Findings:
- Nasal salbutamol administration resulted in favorable responses in all three patients with severe asthma.
- The treatment was effective even in cases refractory to standard therapies.
- No significant undesirable side effects were observed with nasal salbutamol administration.
Implications:
- Nasal salbutamol may represent a viable and effective alternative route for managing severe asthma exacerbations.
- This delivery method could be particularly beneficial for patients unresponsive to conventional treatments.
- Further research into nasal drug delivery for asthma management is warranted.